Aggregated, conformationally changed fibrinogen exposes the stimulating sites for t-PA-catalysed plasminogen activation

Thrombosis and Haemostasis

Volumn 75, Issue 2, 1996, Pages 326-331

  Haddeland, Unni ^a,c   Sletten, Knut ^a   Bennick, Anne ^a   Nieuwenhuizen, Willem ^b   Brosstad, Frank ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b TNO   (Netherlands)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FIBRINOGEN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL PERMEATION CHROMATOGRAPHY; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION;

EID: 0030007244     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650269     Document Type: Article

References (34)

1. Kudryk BJ, Collen D, Woods KR, Blombäck B. Evidence for localization of polymerization sites in fibrinogen. J Biol Chem 1974; 249: 3322-5.
2. Olexa SA, Budzynski AZ. Localization of a fibrin polymerization site. J Biol Chem 1981; 256: 3544-9.
3. Olexa SA, Budzynski AZ. Evidence for four different polymerization sites involved in human fibrin formation. Proc Natl Acad Sci USA 1980; 77: 1374-8.
4. Rozenfeld MA, Vasileva MV. Mechanism of aggregation of fibrinogen molecules: the influence of fibrin-stabilising factor. Biomed Sci 1991; 2: 155-61.
5. Gollwitzer R, Bode W, Karges HE. On the aggregation of fibrinogen molecules. Thromb Res 1983; suppl. 5: 41-53.
6. Cohen G, Stayter H, Kucera J, Hall C. Polymorphism in fibrinogen aggregates. J Mol Biol 1966; 22: 385-8.
7. Becker CM. Bovine fibrinogen aggregate: electron microscopic observations of quasi-globular structures. Thromb Res 1987; 48: 101-10.
8. Laudano AP, Doolittle RF. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. Proc Natl Acad Sci USA 1978; 75: 3085-9.
9. Suenson E, Petersen LC. Fibrin and plasminogen structures essential to stimulation of plasmin formation by tissue-type plasminogen activator Biochim Biophys Acta 1986; 870: 510-9.
10. Verheijen JH, Nieuwenhuizen W, Wijngaards G. Activation of plasminogen by tissue activator is increased specifically in the presence of certain soluble fibrin(ogen) fragments. Thromb Res 1982; 27: 377-85.
11. Dunn FW, Deguchi K, Soria J, Soria C, Lijnen HR, Tobelem G, Caen J. Importance of the interaction between plasminogen and fibrin for plasminogen activation by tissue-type plasminogen activator. Thromb Res 1984; 36: 345-51.
12. Rånby M. Studies on the kinetics of plasminogen activation by tissue plasminogen activator. Biochim Biophys Acta 1982; 704: 461-9.
13. Fisher BE, Will H. Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator. Biochim Biophys Acta 1990; 1041: 48-54.
14. Nieuwenhuizen W, Verheijen JH, Vermond A, Chang GTG. Plasminogen activation by tissue activator is accelerated in the presence of fibrin(ogen) cyanogen bromide fragment FCB-2. Biochim Biophys Acta 1983; 755: 531-3.
15. Yonekawa O, Voskuilen M, Nieuwenhuizen W. Localization in the fibrinogen α-chain of a new site that is involved in the acceleration of the tissue-type plasminogen activator-catalysed activation of plasminogen. Biochem J 1992; 283: 187-91.
16. Yonekawa O, Vermond A, Nieuwenhuizen W. Localization of a new site in fibrin involved in the acceleration of the tissue-type plasminogen activator (t-PA)-catalysed activation of plasminogen. In: Fibrinogen. Current basic and clinical aspects. Matsuda M, Iwanaga S, Takada A, Henschen A, eds. Exerpta Medica, Amsterdam 1990; 4: pp 111-6.
17. Voskuilen M, Vermond A, Veeneman GH, Van Boom JH, Klasen EA, Zegers ND, Nieuwenhuizen W. Fibrinogen lysine residue A alpha 157 plays a crucial role in the fibrin induced acceleration of plasminogen activation, catalysed by tissue-type plasminogen activator. J Biol Chem 1987; 262: 5944-6.
18. Schielen WIG, Adams HPHM, van Leuven K, Voskuilen M, Tesser GI, Nieuwenhuizen W. The sequence γ-(312-324) is a fibrin-specific epitope. Blood 1991; 77: 2169-73.
19. Schielen WJG, Voskuilen M, Tesser GI, Nieuwenhuizen The sequence Aα-(148-160) in fibrin, but not in fibrinogen, is accessible to monoclonal antibodies. Proc Natl Acad Sci USA 1989; 86: 8951-4.
20. Procyk R, Medved L, Engelke KJ, Kudryk B, Blombäck B. Non clottable Fibrin Obtained from Partially Reduced Fibrinogen: Characterization and Tissue Plasminogen Activator Stimulation. Biochemistry 1992; 31: 2273-8.
21. de Serrano VS, Urano T, Gaffney PJ, Castellino FJ. Influence of Various Structural Domains of Fibrinogen and Fibrin on the Potentiation of Plasminogen Activation by Recombinant Tissue Plasminogen Activator. J Protein Chemistry 1989; 8: 61-77.
22. Haddeland U, Sletten K, Bennick A, Brosstad F. Freeze-dried fibrinogen or fibrinogen in EDTA stimulate the tissue plasminogen activator-catalysed conversion of plasminogen to plasmin. Blood Coag Fibrinol 1994; 5: 575-81.
23. Hoegee-De Nobel E, Voskuilen M, Brommer EJP, Nieuwenhuizen W. A monoclonal antibody-based quantitative enzyme immunoassay for the determination of plasma fibrinogen concentration. Thromb Haemost 1988; 60: 415-8.
24. Jakobsen E, Kierulf P. A modified beta-alanine precipitation procedure to prepare fibrinogen free of anti-thrombin III and plasminogen. Thromb Res 1973; 3: 145-59.
25. Jacobsson K. Studies on the determination of fibrinogen in human blood plasma. Scand J Clin Lab Invest 1955; 7: 1-54.
26. Blombäck B. On the properties of fibrinogen and fibrin. Arkiv för kemi 1958; 12: 99-113.
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227; 680-5.
28. Burnette WN. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulphate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981; 112: 195-203.
29. Grøn B, Filion-Myklebust C, Bennick A, Nieuwenhuizen W, Matsueda GR, Brosstad F. Early cross-linked fibrin in human plasma contains α-polymers with intact fibrinopeptide A. Blood Coag Fibrinol 1992; 3: 731-6.
30. Nieuwenhuizen W, Voskuilen M, Matsuda M, Haverkate F, Koopman J, Briët E, Janzarik H. Abnormal fibrins defective in the exposure of sites involved in the acceleration of t-PA mediated plasminogen activation. Fibrinolysis 1994; 8 (suppl. 1): abstract 265.
31. Radcliffe R, Heinze T. Stimulation of tissue plasminogen activator by denatured proteins and fibrin clots: a possible additional role for plasminogen activator. Arch Biochem Biophys 1981; 211: 750-61.
32. Soeda S, Shimeno H, Nagamatsu A. A comparison of bovine serum albumins, modified with a variety of carboxyl group agents, as stimulators of tissue-type plasminogen activator-catalysed activation of plasminogen. Chem Pharm Bull 1989; 37: 723-8.
33. Mosesson MW, Siebenlist KR, Hainfeld JF, Wall JS. The covalent structure of factor XIIIa-crosslinked fibrinogen fibrils. In press, Jour Structural Biol, 1995.
34. Haddeland U, Bennick A, Brosstad F. Stimulating effect on tissue-type plasminogen activator - a new and sensitive indicator of denatured fibrinogen. Thromb Res 1995; 77: 329-36